Matches in Wikidata for { <http://www.wikidata.org/entity/Q84244349> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q84244349 description "article scientifique publié en 2012" @default.
- Q84244349 description "artículu científicu espublizáu en xunu de 2012" @default.
- Q84244349 description "im Juni 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q84244349 description "scientific article published on 01 June 2012" @default.
- Q84244349 description "wetenschappelijk artikel" @default.
- Q84244349 description "наукова стаття, опублікована в червні 2012" @default.
- Q84244349 name "[A medical-pharmaceutical partnership model as a contributor to the success in conditioning regimen for allogenic hematopoietic stem cell transplantation in adults: a cross-reflection on our organizations]" @default.
- Q84244349 name "[A medical-pharmaceutical partnership model as a contributor to the success in conditioning regimen for allogenic hematopoietic stem cell transplantation in adults: a cross-reflection on our organizations]" @default.
- Q84244349 type Item @default.
- Q84244349 label "[A medical-pharmaceutical partnership model as a contributor to the success in conditioning regimen for allogenic hematopoietic stem cell transplantation in adults: a cross-reflection on our organizations]" @default.
- Q84244349 label "[A medical-pharmaceutical partnership model as a contributor to the success in conditioning regimen for allogenic hematopoietic stem cell transplantation in adults: a cross-reflection on our organizations]" @default.
- Q84244349 prefLabel "[A medical-pharmaceutical partnership model as a contributor to the success in conditioning regimen for allogenic hematopoietic stem cell transplantation in adults: a cross-reflection on our organizations]" @default.
- Q84244349 prefLabel "[A medical-pharmaceutical partnership model as a contributor to the success in conditioning regimen for allogenic hematopoietic stem cell transplantation in adults: a cross-reflection on our organizations]" @default.
- Q84244349 P1433 Q84244349-D06E9D76-E5D4-49DB-8AAD-A53017B37890 @default.
- Q84244349 P1476 Q84244349-03666A96-C354-44BC-B977-2A3ED44D977D @default.
- Q84244349 P2093 Q84244349-37698DBE-5308-48FA-9E7A-EE9A4C78E7F6 @default.
- Q84244349 P2093 Q84244349-402287F1-65CF-4CC3-B270-DCF91BD7E341 @default.
- Q84244349 P2093 Q84244349-50EB849A-D5EC-4138-B961-BD56A0799F8C @default.
- Q84244349 P2093 Q84244349-55A4A054-6828-4F87-85EE-7D44200491E6 @default.
- Q84244349 P2093 Q84244349-63120189-E3EB-4CF2-8178-E506A274076D @default.
- Q84244349 P2093 Q84244349-B39F77D8-85D9-41A5-8B2E-230C03F1EC34 @default.
- Q84244349 P2093 Q84244349-B79CCCA2-56C8-45F7-96A0-F434DE02E4CE @default.
- Q84244349 P2093 Q84244349-BBDDB12B-0672-4319-9E9A-59D27DCEE41C @default.
- Q84244349 P2093 Q84244349-DF97CF5A-1F9A-44C8-BD0E-9E54E80B4161 @default.
- Q84244349 P2093 Q84244349-E48A4896-7FEA-4AC6-B319-00BD1B9B53A6 @default.
- Q84244349 P2093 Q84244349-EA199163-8945-42E2-8C2E-0F54F05B1872 @default.
- Q84244349 P2093 Q84244349-EA5ADAC9-3690-494C-9066-0587F040D42B @default.
- Q84244349 P304 Q84244349-4F7F20D4-7D4F-4B67-B85E-7C644980B33F @default.
- Q84244349 P31 Q84244349-6FBBDE95-4099-4704-9E2D-029450758650 @default.
- Q84244349 P356 Q84244349-F9559340-AB55-4250-BD6D-ACD0A9444974 @default.
- Q84244349 P433 Q84244349-5EE30AB4-5B83-4880-B0B3-BDC64D7FC656 @default.
- Q84244349 P478 Q84244349-57AA031A-7676-4EDC-A7E7-20E64FEAD113 @default.
- Q84244349 P50 Q84244349-05B23B91-628E-4B64-976F-860EC8CBB353 @default.
- Q84244349 P50 Q84244349-1EE90861-289A-458B-BF7E-B6DE25155691 @default.
- Q84244349 P50 Q84244349-B0D86099-9CD1-4B57-85EF-427B9E918224 @default.
- Q84244349 P577 Q84244349-EC019D0B-40AF-4D94-9271-B57807CCA907 @default.
- Q84244349 P698 Q84244349-47DA7D6B-0935-42C1-8EC3-04AEB6D180A9 @default.
- Q84244349 P921 Q84244349-9409DA66-81E3-4F17-87CF-82945462D79D @default.
- Q84244349 P356 BDC.2012.1589 @default.
- Q84244349 P698 22645281 @default.
- Q84244349 P1433 Q26853996 @default.
- Q84244349 P1476 "[A medical-pharmaceutical partnership model as a contributor to the success in conditioning regimen for allogenic hematopoietic stem cell transplantation in adults: a cross-reflection on our organizations]" @default.
- Q84244349 P2093 "Bérénice Giraud" @default.
- Q84244349 P2093 "Caroline Trompette" @default.
- Q84244349 P2093 "Christine Broissand" @default.
- Q84244349 P2093 "Christophe Merlette" @default.
- Q84244349 P2093 "David Sibon" @default.
- Q84244349 P2093 "Dominique Blot" @default.
- Q84244349 P2093 "Felipe Suarez" @default.
- Q84244349 P2093 "Ludivine Falaschi" @default.
- Q84244349 P2093 "Odile Corriol" @default.
- Q84244349 P2093 "Philippe Bourget" @default.
- Q84244349 P2093 "Rozenn Clement" @default.
- Q84244349 P2093 "Valérie Galland" @default.
- Q84244349 P304 "643-653" @default.
- Q84244349 P31 Q13442814 @default.
- Q84244349 P356 "10.1684/BDC.2012.1589" @default.
- Q84244349 P433 "6" @default.
- Q84244349 P478 "99" @default.
- Q84244349 P50 Q105684410 @default.
- Q84244349 P50 Q28322530 @default.
- Q84244349 P50 Q55241405 @default.
- Q84244349 P577 "2012-06-01T00:00:00Z" @default.
- Q84244349 P698 "22645281" @default.
- Q84244349 P921 Q65592366 @default.